The Tisch Cancer Institute is a vital component of the Icahn School of Medicine at Mount Sinai Hospital and plays a key role in the Mount Sinai Health System, which is one of the largest health care systems in the nation. We are a National Cancer Institute (NCI)-designated center and provide a multidisciplinary approach to cancer treatments and clinical breakthroughs that may one day put an end to cancer. Our Cancer Clinical Trials Office (CCTO) provides the infrastructure and resources required to support patient-based cancer research. The CCTO is composed of regulatory, financial, clinical, study management, and data management personnel that support our disease management teams. We are a growing enterprise and have multiple, exciting opportunities for Clinical Research Nurses, Nurse Managers, and support staff to join our team.
Qualified applicants should possess a Bachelor's of Science, a BSN for nursing related positions, experience in a medical or clinical research environment, be comfortable with working in a team setting, excellent written and oral communication skills, and an ability to manage multiple tasks & priorities. For additional information, and/or to apply to one of our open positions, please contact Amina Dixon (Administrative Manager) at firstname.lastname@example.org or visit the Mt. Sinai career page at https://careers.mountsinai.org/
About The Tisch Cancer Institute
The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, which includes seven hospital campuses, and has more than 5,000 faculty and nearly 2,000 students, residents and fellows. Our unwavering pursuit of intellectual exchange, breakthrough research, and multidisciplinary teamwork propels us ever forward in biomedical discoveries and advances. We pursue ideas that often challenge conventional wisdom to revolutionize the practice of medicine and produce dramatically better outcomes for patients. We make big, bold bets by investing in radical free thinkers and technology at the cutting edge.